Health

Quitting smoking drug Chantix: FDA warns of alcohol, seizure risks

Quitting smoking drug Chantix: FDA warns of alcohol, seizure risks

Quitting smoking drug Chantix: FDA warns of alcohol, seizure risks 

Pfizer’s drug Chantix is very popular among the people trying to quit smoking. This is a drug that seems to be most effective for people wishing to give up smoking.

Now many people will think twice before actually using the drug. The U.S. Food and Drug Administration has come out with a warning that the drug may actually cause seizures and that some patients who drink while taking the drug may become aggressive or black out.

This is going to have very negative consequences for Pfizer in general and its drug Chantix in particular. The USFDA has also said that it has agreed upon an update to the drug’s label in September but issued the public notice to ensure patients are aware of the changes.

ALCOHOLThe USFDA went on to add that the announcement is intended for users so that they “can consider this new information when making prescribing decisions.”

Though, not many people use drugs while trying to give up smoking but whoever uses medicine Chantix is among the top choice. The drug is known chemically as varenicline and it was approved in the year 2006. The FDA subsequently updated the label to include a warning, highlighted by a black box, of neuropsychiatric side effects, including suicidal thoughts, hostility and agitation.

Nonetheless the drug manufacturer has actually requested the FDA to do away with black box, saying its own studies show no association between Chantix and severe psychiatric side effects. But FDA has refused to oblige. In October an FDA advisory committee recommended keeping the black box pending the outcome of an ongoing safety study.

chantix side effects seizures, chantix side effects alcohol, chantix side effects nausea, chantix side effects weight loss, chantix side effects anger, chantix side effects

More in Health